Soleno Therapeutics (SLNO) 10-K2020 FY Annual report

Filed: 3 Mar 21, 4:05pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: acid, adaptive, AgRP, assent, biopharmaceutical, brain, butyric, capsule, carryback, comfortably, contactor, context, convincing, COVID, CRO, dorsal, downturn, economy, essential, Eurasia, Fragile, Glycogen, heighten, hirsutism, home, hyperinsulinemia, hyperinsulinemic, hyperpolarization, hypoglycemia, incentivizing, insulin, landlord, leptin, melanocortin, MHRA, mode, motor, neuropeptide, NPY, onset, optimistic, oxidation, pancreatic, pandemic, pathophysiological, pathophysiology, peptile, perpetuation, Phenotype, physiological, potent, problem, problematic, proclaimed, reserved, resistance, reward, risky, role, root, satiety, slightly, society, spread, stay, Syndromeour, therefrom, topline, triglyceride, unique, visit, weaken, weakening, withdrawn, Wuhan

Removed: advancing, affixed, Agonizing, AIA, Allergy, anniversary, applicability, appointed, appointment, Aspire, assuming, assumption, authoritative, back, bifurcation, blood, carbon, CNS, comparative, Comparison, conclusion, conserve, constipation, conversion, David, degrade, diligence, dispose, distinguishing, divest, doubt, ear, embedded, emerging, estimable, ETCO, excessive, exempt, FLG, friction, gas, glucose, GLWL, host, hybrid, hypersomnia, impaired, indefinite, indemnification, infection, Jack, Jonathan, leadership, licensor, long, marked, metering, modified, modulation, monoxide, moved, Neo, neurological, noncontrolling, Oracle, outlined, precision, preclude, reclassified, recourse, recoverability, red, redeemable, redemption, retrospective, reviewed, Rhythm, royalty, Sabby, Schuler, Serenz, SLNOW, somnolence, style, sublicense, substantive, surgical, temperature, turnover, unclear, view, wide, Wolter

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

SLNO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

We consent to the incorporation by reference in the Registration Statement of Soleno Therapeutics, Inc. on Form S-8 (File No.’s 333-200175, 333-210563, 333-220056, 333-224070, 333-230402, 333-235999, 333-239496, 333-252014 and 333-252108) and Form S-3 (File No. 333-232068) of our report dated March 3, 2021, with respect to our audits of the consolidated financial statements of Soleno Therapeutics, Inc. as of December 31, 2020 and 2019 and for each of the two years in the period ended December 31, 2020, which report is included in this Annual Report on Form 10-K of Soleno Therapeutics, Inc. for the year ended December 31, 2020.

/s/ Marcum LLP

Marcum LLP

San Francisco, CA

March 3, 2021